Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19

We assessed the performance of Abbott's SARS-CoV-2 IgG assay and the Panbio(TM) COVID-19 IgG/IgM rapid test device for the diagnosis of either active or cured COVID-19. Three cohorts of patients were chosen. Cohort 1, patients (n = 65) who attended the emergency department on March 30, 2020 wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Escribano, Pilar, Álvarez-Uría, Ana, Alonso, Roberto, Catalán, Pilar, Alcalá, Luis, Muñoz, Patricia, Guinea, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669901/
https://www.ncbi.nlm.nih.gov/pubmed/33199713
http://dx.doi.org/10.1038/s41598-020-76914-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669901/
https://www.ncbi.nlm.nih.gov/pubmed/33199713
http://dx.doi.org/10.1038/s41598-020-76914-5

Ejemplares similares